Biovie Inc (US: BIVI) — Healthcare · Share Price, Chart & Market Data
About: BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.50 (+4.90%)
BIVIBiovie Inc
Loading watchlist status…
Trade BIVI now
Biovie Inc share price
BIVI price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:06 am GMT+0
BIVI price performance
-5.063%
5D
10.294%
1M
12.782%
YTD
-82.357%
1Y
BIVI price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:06 am GMT+0
BIVI details
BIVI Market Signals